JP Stock MarketDetailed Quotes
4884 KRINGLE PHARMA
- 666
- -23-3.34%
20min DelayMarket Closed May 29 15:00 JST
4.38BMarket Cap-4202P/E (Static)
689High662Low148.90KVolume670Open689Pre Close99.98MTurnover103752wk High3.29%Turnover Ratio6.57MShares39452wk Low-160.04EPS TTM3.01BFloat Cap1780Historical HighLossP/E (Static)4.52MShs Float394Historical Low-158.46EPS LYR3.92%Amplitude--Dividend TTM1.88P/B100Lot Size--Div YieldTTM
About KRINGLE PHARMA Company
Kringle Pharma Inc is engaged in the research and development of HGF (hepatocyte growth factor) protein as a therapeutic agent for intractable diseases.
Company Profile
Symbol4884
Company NameKRINGLE PHARMA
Founded2001-12-21
MarketTSE Growth
Fiscal Year Ends09-30
Address7-7-15 Saitoasagi 207 Saito Bio-Incubator
Zip Code567-0085
Phone072-641-8739
Websitewww.kringle-pharma.com
Company Executives
- Name
- Position
- Salary
- Yoshiyuki Kayano
- Director and Reliability Assurance Manager
- --
- Yoshikazu Adachi
- Representative Director and President
- --
- Tomoho Masataku
- Director
- --
- Koichi Murakami
- Director and Director of Business Administration
- --
- Daima Hayata
- Director, Director of Pharmaceutical Development and Director of Pharmaceutical Affairs
- --
- Masato Fukui
- Independent Director
- --
- Koichiro Yoshino
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
%Chg